Sale of a Multinational Medical Supplies Company

The target is a wholly foreign-owned manufacturing facility in China operated by a multinational medical supplies company. It has a well-established production system and comprehensive quality management capabilities. As part of the group’s global strategic realignment, the company decided to divest its China manufacturing operation and related assets.

Reignite Med Tech Pharma was appointed as the transaction advisor to develop the divestment strategy, identify and screen prospective buyers, and lead commercial negotiations. Reignite successfully introduced a suitable acquirer, and the parties have signed a Letter of Intent (LOI). Due diligence and the subsequent transaction process are currently progressing in an orderly manner.

Estimated transaction value: approximately EUR 30 million.